The first-ever platform for comprehensively programmable medicines.
We are creating new classes of programmable medicines with a unique approach that deconstructs a rich and under-explored programming language provided by nature.
Reaching full programmability
Senda applies deep molecular profiling and advanced analytics to natural nanoparticles and information molecules, like mRNA. By combining our knowledge from both, we can program both within and to the cell.
How our platform works
Identify and map
First, we apply high-resolution molecular profiling to measure the compositions of natural nanoparticles spanning the tree of life—building a unique database of the subcomponents of natural nanoparticles.
Program to the cell
Next, we use the Atlas to program nanoparticles with desired bioproperties, such as targeting to a specific tissue or cell.
Program within the cell
Our mRNA engine enables programming and synthesis of mRNA for the specific properties, including sub-cellular localization and therapeutic function we intend to drive within the cell.
Next, we combine our programmed mRNA and nanoparticles to create SendRNA medicines that are subsequently evaluated in an experimental system.
Expanding our programming capabilities
Experimental data for SendRNAs are loaded into a digital backbone that informs an ever-expanding body of information and enables application of advanced analytics—including artificial intelligence and machine learning—to continually enhance the programming of SendRNAs.
Creating better medicines faster
Molecules profiled and mapped in the Senda Atlas
Unique SendRNAs already programmed and tested successfully in pre-clinical studies conducted in rodents or non-human primates
Current time from extraction to functional readout for one SendRNA